PrestoDoctor Expands Into Michigan Ahead of New Cannabis Tax Changes Strategic market entry positions company for growth as Michigan prepares for 2026 tax reforms GlobeNewswire October 21, 2025 Mesquite, NV, Oct. 21, 2025 (GLOBE NEWSWIRE) — Mesquite, NV — October 21, 2025 — Dogecoin Cash, Inc. (OTCQB: DOGP) subsidiary PrestoDoctor, a national leader in cannabis […]
Best Practice by World-class Experts in Proton Therapy Transforming Precision Cancer Management HKSH Medical Group (HKSH) introduced Hong Kong's only and the Greater Bay Area's first proton therapy system in 2023, after two decades of planning and preparation. Now that the HKSH Proton Therapy Centre has been in operation for two years, following the “Proton
WUHU, China, Oct. 21, 2025 (GLOBE NEWSWIRE) — From October 17 to 20, 2025, the 'Innovation — Defining the Future' — JETOUR JMA Global Media Alliance Tech Tour was held in Wuhu, Anhui Province. Media representatives from around the world visited JETOUR's headquarters to participate in a series of immersive activities, including technology exhibitions, product
Innovation– Defining the Future: JETOUR JMA Global Media Alliance Tech Tour Kicks Off GlobeNewswire October 21, 2025 WUHU, China, Oct. 21, 2025 (GLOBE NEWSWIRE) — From October 17 to 20, 2025, the 'Innovation — Defining the Future' — JETOUR JMA Global Media Alliance Tech Tour was held in Wuhu, Anhui Province. Media representatives from around
(CNSX:ROBO.CN),(Boerse Frankfurt – Freiverkehr:0XM1),(Pinksheets:TRMNF),(PinkSheets:TRMNF),(Pinksheets:RBOHF),(PinkSheets:RBOHF), Vancouver, BC & Chicago, Illinois, Oct. 21, 2025 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company“) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce that
Disease modifying mechanism of action: short treatment course results in significant and durable clinical response in psoriasis patients si-544 is the first highly potent and selective Kv1.3 blocker to safely achieve patient plasma levels suitable for high target engagement Excellent safety and tolerability consistent with prior clinical experience; no dose-limiting toxicities and no serious safety
The expanded all-on-one Nuron portfolio enables a fully cordless jobsite with more heavy-duty applications than ever using a single, interchangeable battery system with a higher power output Hilti North America,a global leader providinginnovative tools, technology, software, and services to the commercial construction industry, announces the expansion of the Nuron cordless portfolio with more than 60
selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease GlobeNewswire October 21, 2025 Disease modifying mechanism of action: short treatment course results in significant and durable clinical response in psoriasis patients si-544 is the first highly potent and selective
Humanoid Global Announces Commitment to a Strategic Investment in Formic to Accelerate the Adoption of Autonomous Robotics in Manufacturing – NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – GlobeNewswire October 21, 2025 Vancouver, BC & Chicago, Illinois, Oct. 21, 2025 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or
On October 19, the 2025Antai College Advisory Board Meeting of Antai College of Economics and Management (ACEM), Shanghai Jiao Tong University (SJTU), was held at the SJTU Xuhui Campus. Nearly forty domestic and international guests from the political, academic, and business sectors attended the meeting, sharing valuable insights to support the high-quality development of the